Summit Partners Public Asset Management’s GeneDx Holdings WGS Stock Holding History

Summit Partners Public Asset Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-479,418	Closed	-$30.8M	–	224
2026 Q1	$30.8M	Sell	479,418 -441,169	-48%	-$40.2M	0.83%	42
2025 Q4	$120M	Buy	920,587 +97,020	+12%	+$13.3M	2.49%	6
2025 Q3	$88.7M	Buy	823,567 +56,302	+7%	+$6.13M	1.84%	12
2025 Q2	$70.8M	Sell	767,265 -435,264	-36%	-$34.2M	1.79%	13
2025 Q1	$107M	Buy	1,202,529 +446,965	+59%	+$38.8M	2.74%	4
2024 Q4	$58.1M	Buy	755,564 +582,619	+337%	+$40.7M	1.11%	28
2024 Q3	$7.34M	Buy	+172,945	New	+$5.84M	0.23%	85

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Summit Partners Public Asset Management's WGS Position: Q2 2026 in Review

Summit Partners Public Asset Management sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 479,418 shares — an estimated $30.8M sold.

Summit Partners Public Asset Management first reported a position in WGS in Q3 2024 and held it in 7 quarters. The position peaked at $120M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Summit Partners Public Asset Management reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Summit Partners Public Asset Management sold 479,418 GeneDx Holdings shares in Q2 2026, an estimated $30.8M.
Summit Partners Public Asset Management first reported a position in GeneDx Holdings in Q3 2024 and held it in 7 quarters.
Summit Partners Public Asset Management's GeneDx Holdings position peaked at $120M in Q4 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.